• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL CIRCULATION AUTOPULSE PLATFORM RESUSCITATION; CARDIAC CHEST COMPRESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL CIRCULATION AUTOPULSE PLATFORM RESUSCITATION; CARDIAC CHEST COMPRESSOR Back to Search Results
Model Number MODEL 100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Laceration(s) (1946); Internal Organ Perforation (1987); Multiple Fractures (4519)
Event Date 08/31/2020
Event Type  Injury  
Manufacturer Narrative
Based on archive data review on the reported event date of (b)(6) 2020, the autopulse platform (sn (b)(4) performed as intended.No user advisory (ua) or system error messages was observed.During investigation on (b)(6) 2020, the autopulse platform, the platform displayed user advisory (ua) 41 (patient temperature sensor failure) upon power up.Following this, the platform was restarted a few times, and ua 41 was cleared.The platform was tested with the large resuscitation test fixture (lrtf) equivalent to 280 lbs.With good known test batteries until discharged without any fault or error.As a precautionary measure, the temperature sensor was replaced.The root cause of the defective temperature sensor in which is likely attributed to normal wear and tear.The autopulse platform was manufactured in 29 september 2020 and has a serviceable life of 5 years.This observation is not related to the reported complaint.After service completion, the autopulse was subjected to the run-in test using the 95% patient large resuscitation test fixture (lrtf) with good known test battery until discharged without any fault or error.The autopulse platform passed all functional tests.Per medical safety assessment, chest compression, as a part of cardiopulmonary resuscitation (cpr), has a high rate of patient adverse events.Common skin damage, common skeletal injuries (rib, sternum and spine fracture), common internal organ injuries (liver and spleen), and common clinical events secondary to those injuries (pneumothorax, diaphragmatic injury) are expected adverse event for both manual and mechanical cprs.The chest compression generated by the autopulse system may lead to an injury profile that is no worse than manual cpr.Similarly, a randomized trial of manual cpr and phased manual plus autopulse cpr found no difference in cardiac, pulmonary or cerebral damage.Complications in autopulse-treated patients occurred at a rate not exceeding that of manual cpr.The aha guidelines 2000 states, "concern for injuries that may complicate cpr should not impede prompt and energetic application of cpr.The only alternative to timely initiation of effective cpr for the victim of cardiac arrest is death." the released guidelines 2005 deliver a similar message, "rib fractures and other injuries are common but acceptable consequences of cpr given the alternative of death from cardiac arrest." rib fracture can be caused by manual cpr as well as with the mechanical cpr.The event was probably related to the device since the connection of the reported injury to the device cannot be ruled out.Perforation of diaphragm can be caused by manual cpr as well as with the mechanical cpr.The event was probably related to the device since the connection of the reported injury to the device cannot be ruled out.Splenic laceration/subcapsular hemorrhage can be caused by manual cpr as well as with the mechanical cpr.The event was probably related to the device since the connection of the reported injury to the device cannot be ruled out.The patient's death was not related to the autopulse device.Out-of-hospital cardiac arrest (ohca) is one of the main causes of death in industrial nations.About 25% of patients survive this event and make it to the hospital, and even fewer patients survive after 24 hours (nichol, nejm, 2015).In the united states, survival to hospital discharge after non-traumatic emergency medical services-treated cardiac arrest with any first recorded rhythm was 10.6% for patients of any age.Of the bystander-witnessed out-of-hospital cardiac arrests in 2011, 31.4% of victims survived to hospital discharge (mozaffarian, circulation, 2016).Death is an expected outcome for ohca.
 
Event Description
After the autopulse platform (sn (b)(4) was used on a female patient on cardiac arrest and was transported to (b)(6) hospital for further care.The platform functioned as intended and no malfunction of the platform was reported.During the call, the crew initiated manual cpr and followed with the autopulse platform (sn (b)(4) on a (b)(6) year old female patient on cardiac arrest.The patient was intubated and defibrillated multiple times, including double sequential defibrillation.Total time of resuscitation was approximately 60 minutes.Manual cpr was administered prior to transport from 00:53 to 01:18 and autopulse platform started from 01:18 till 01:52.Rosc (return of spontaneous circulation) was achieved and was transferred to the hospital.The patient arrived with pulse.However, the hospital staff reported that the patient expired.It was reported that the patient had traumatic injuries based on further imaging.It was found that the patient have acute fractures on the left second through eight rib, acute fractures on the second through seventh ribs, splenic laceration/subcapsular hemorrhage and perforation of diaphragm.Finally, dnr (do not resuscitate) was made by patient's family due to multisystem organ failure and risk of subsequent cardiac arrest, and the patient expired in hospital.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOPULSE PLATFORM RESUSCITATION
Type of Device
CARDIAC CHEST COMPRESSOR
Manufacturer (Section D)
ZOLL CIRCULATION
2000 ringwood ave.
san jose CA 95131
Manufacturer (Section G)
ZOLL CIRCULATION
2000 ringwood ave.
san jose CA 95131
Manufacturer Contact
kim thoa nguyen
2000 ringwood ave,
san jose, CA 95131
4084192922
MDR Report Key10624437
MDR Text Key209803188
Report Number3010617000-2020-01039
Device Sequence Number1
Product Code DRM
UDI-Device Identifier00849111000512
UDI-Public00849111000512
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112998
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/03/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/03/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberMODEL 100
Device Catalogue Number8700-0730-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/28/2020
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/05/2020
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/29/2015
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
-
-